Clinical immunology (Orlando, Fla.)

Tissue- and age-specific changes in gene expression during disease induction and progression in NOD mice.

Clinical immunology (Orlando, Fla.)

Kodama K, Butte AJ, Creusot RJ, Su L, Sheng D, Hartnett M, Iwai H, Soares LR, Fathman CG

IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.

Clinical immunology (Orlando, Fla.)

Butte MJ, Haines C, Bonilla FA, Puck J

IL-7 receptor deficient SCID with a unique intronic mutation and post-transplant autoimmunity due to chronic GVHD.

Clinical immunology (Orlando, Fla.)

Butte MJ, Haines C, Bonilla FA, Puck J

A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

Clinical immunology (Orlando, Fla.)

Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS

A robust immunoassay for anti-interferon autoantibodies that is highly specific for patients with autoimmune polyglandular syndrome type 1.

Clinical immunology (Orlando, Fla.)

Zhang L, Barker JM, Babu S, Su M, Stenerson M, Cheng M, Shum A, Zamir E, Badolato R, Law A, Eisenbarth GS, Anderson MS

Mechanisms of PDL1-mediated regulation of autoimmune diabetes.

Clinical immunology (Orlando, Fla.)

Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H, Azuma M, Atkinson M, Bluestone JA, Sayegh MH

Mechanisms of PDL1-mediated regulation of autoimmune diabetes.

Clinical immunology (Orlando, Fla.)

Guleria I, Gubbels Bupp M, Dada S, Fife B, Tang Q, Ansari MJ, Trikudanathan S, Vadivel N, Fiorina P, Yagita H, Azuma M, Atkinson M, Bluestone JA, Sayegh MH

Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.

Clinical immunology (Orlando, Fla.)

Akin C, Soto D, Brittain E, Chhabra A, Schwartz LB, Caughey GH, Metcalfe DD

Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.

Clinical immunology (Orlando, Fla.)

Akin C, Soto D, Brittain E, Chhabra A, Schwartz LB, Caughey GH, Metcalfe DD

HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).

Clinical immunology (Orlando, Fla.)

Vacek MM, Schäffer AA, Davis J, Fischer RE, Dale JK, Adams S, Straus SE, Puck JM

Pages